Genome-environment interactions in the molecular pathogenesis of dilated cardiomyopathy.
about
Cardiac-targeted delivery of regulatory RNA molecules and genes for the treatment of heart failureThe Finnish Cardiovascular Study (FINCAVAS): characterising patients with high risk of cardiovascular morbidity and mortality.Remodeling and dedifferentiation of adult cardiomyocytes during disease and regeneration.Betaferon in chronic viral cardiomyopathy (BICC) trial: Effects of interferon-β treatment in patients with chronic viral cardiomyopathy.Screening of long non-coding RNA and TUG1 inhibits proliferation with TGF-β induction in patients with COPD.Genomic expression profiling of human inflammatory cardiomyopathy (DCMi) suggests novel therapeutic targets.
P2860
Genome-environment interactions in the molecular pathogenesis of dilated cardiomyopathy.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Genome-environment interactions in the molecular pathogenesis of dilated cardiomyopathy.
@ast
Genome-environment interactions in the molecular pathogenesis of dilated cardiomyopathy.
@en
type
label
Genome-environment interactions in the molecular pathogenesis of dilated cardiomyopathy.
@ast
Genome-environment interactions in the molecular pathogenesis of dilated cardiomyopathy.
@en
prefLabel
Genome-environment interactions in the molecular pathogenesis of dilated cardiomyopathy.
@ast
Genome-environment interactions in the molecular pathogenesis of dilated cardiomyopathy.
@en
P2093
P2860
P1476
Genome-environment interactions in the molecular pathogenesis of dilated cardiomyopathy.
@en
P2093
Pauschinger M
Schultheiss HP
Tschoepe C
P2860
P2888
P304
P356
10.1007/S00109-005-0664-2
P577
2005-06-02T00:00:00Z